CellaVision AB (CLVSF)
17.30
+0.30
(+1.76%)
USD |
OTCM |
Jan 21, 16:00
CellaVision EPS Diluted (Quarterly): 0.1381 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vivesto AB | -0.0037 |
| BioInvent International AB | -0.2063 |
| Hansa Biopharma AB | -0.1838 |
| BioArctic AB | -0.103 |
| Camurus AB | 0.3356 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.293M |
| Revenue (Quarterly) | 18.45M |
| Total Expenses (Quarterly) | 15.16M |
| Enterprise Value | 398.66M |
| Gross Profit Margin (Quarterly) | 69.07% |
| Profit Margin (Quarterly) | 17.84% |
| Earnings Yield | 3.60% |
| Operating Earnings Yield | 4.72% |
| Normalized Earnings Yield | 3.604 |